Artificial Intelligence & gene therapy to revolutionize human health – Xiaoling Li, Triastek
Xiaoling Li is a Professor of Pharmaceutics and Associate Dean of Graduate Education and Research in Thomas J. Long School of Pharmacy and Health Sciences at the University of the Pacific. He is Co-founder and Chief Scientific Officer, Triastek, Inc., China. Xiaoling Li will speak about Application of 3D Printing Technology in Dosage Form Design and Drug Delivery during the 3D Medical Printing Conference, which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.
What drives you?
Innovation, science and technology Continue reading “Artificial Intelligence & gene therapy to revolutionize human health – Xiaoling Li, Triastek”